Treatment of Recurrent HGG Patients with the Retroviral Replicating Vector Toca 511 and Toca FC Gives Durable Responses and Survival Lasting 3 Years or Longer: Immune Mechanisms and Molecular Analyses of Tumors
MOLECULAR THERAPY（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要